Revive Therapeutics (RVVTF) Advancing MDMA Thermal Patch.
Two News Reports Related to Revives Upcoming Microneedle Patch Technology
While we are still laser focused on Revive...
SILO Pharma (SILO) Gains 53%
For Now, Volatility Remains and the Traders, Seem to be Having the Most Fun.
Silo Pharma Gains 53%...
Citius Pharma (CTXR). Reports Fiscal First Quarter 2023 Financial Results and Provides Business Update
$36.9 million in cash and cash equivalents as of December 31, 2022 ; runway through February 2024
Society Pass (SOPA) $1.15 Breaks Above First Line of Resistance.
If you're familiar with the term, "..the stars are aligning" here is a real life example. If you're familiar with the term,...
Silo Pharma (SILO) $2.67 Announces $1 Million Stock Buyback.
Yes it doesn't sound like a lot of money on the surface. But the stock is so grossly undervalued (in our opinion)...
Initiating Coverage on Society Pass (SOPA).
Institutional Analyst: Society Pass (Nasdaq: SOPA) - Acquiring and Incubating Startups in the Heart of the Asian Silicon Valley
Society Pass (SOPA) Research Reports
RESEARCH REPORT ARCHIVE
December 27th, 2023. Litchfield Hills Research - $4.00 Price Target.
Silo Pharma (SILO) Announces Positive Study Results of SPU- 21 for Arthritis
SPU-21 effective in controlling arthritis progression.
SPU-21 Demonstrates Positive Data in Arthritis Suppression using Silo’s Novel Joint Homing Peptide
Smart for Life (SMFL) Announces Launch of Greens First Protein Bars.
New Line of Protein Bars Specifically Formulated with the Greens First PRO Line, Provides a Nutrient Dense Meal Replacement with 54 Super...
Can Lightning Strike Twice? Mitesco (MITI, MITID) Health Clinics.
Mitesco one of our Past Clients, Gained 10-Fold After we Added it to the Watch List, Just did a Reverse Split...
Latest article
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
GeoVax (GOVX) Launches Vaccine Manufacturing System.
GeoVax Achieves Milestone in Transition to Commercially Validated Manufacturing System
Manufacturing Process for Phase 3 and Commercial Production...
Experts From Harvard, Scripps Research Institute, the University Hospital Zürich, and the Former Chief...
Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody...
